Sight Sciences is dedicated to advancing eyecare through innovative, interventional technologies that aim to improve patient outcomes and elevate the standard of care. Their flagship product, the OMNI® Surgical System, is an implant-free technology designed for glaucoma surgery, specifically targeting the reduction of intraocular pressure in patients with primary open-angle glaucoma. This system allows for a comprehensive approach by addressing multiple areas of resistance within the eye, including the trabecular meshwork and Schlemm’s canal. Additionally, the SION® Surgical Instrument offers a bladeless, manually operated solution for excising trabecular meshwork during ophthalmic procedures, enhancing the safety and efficacy of glaucoma treatments.

In the realm of dry eye disease, Sight Sciences has developed the TearCare® System, which utilizes localized heat therapy to treat meibomian gland dysfunction (MGD), a leading cause of evaporative dry eye. This system enables healthcare providers to clear gland obstructions effectively, offering a less invasive alternative to traditional treatments. By focusing on the underlying causes of prevalent eye diseases and promoting earlier intervention, Sight Sciences is committed to transforming the landscape of eyecare and ensuring that patients can maintain their vision and quality of life.

United States

We are reimagining eyecare with transformative technology and an interventional mindset. We believe interventions should happen sooner to preserve, protect, or restore natural eye function. So, we aim to provide eyecare providers with transformative, clinically-proven therapies that are intuitive, less invasive, and more intelligent.

Sight Sciences

Company Details